Indocyanine Green-Loaded Photoacoustic Nanodroplets: Dual Contrast Nanoconstructs for Enhanced Photoacoustic and Ultrasound Imaging
Source abstract
Abstract
Recently, perfluorocarbon (PFC) nanodroplets were introduced as contrast agents for imaging and image-guided therapy. For example, in sonography, high-intensity ultrasound pulses were used to phase-transition liquid perfluorocarbon to produce gas microbubbles. More recently, perfluorocarbon nanodroplets with encapsulated gold nanorods were used as dual ultrasound/photoacoustic contrast agents. To expedite clinical translation, we synthesized and characterized ICG-loaded perfluorocarbon nanodroplets, i.e., constructs comprising biocompatible, nontoxic and biologically safe materials. We then demonstrated enhanced photoacoustic contrast through optically triggered phase transition of PFC nanodroplets and ultrasound contrast from the resulting PFC bubbles. We assessed the quality enhancement of photoacoustic and ultrasound images through analysis of contrast and contrast-to-noise ratio. We further investigated the changes in image contrast due to increased ambient temperature. Our studies suggest that ICG-loaded perfluorocarbon nanodroplets may become a valuable tool for various imaging modalities, and have promising therapeutic applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Ultrasound and Hyperthermia Applications · Thermoregulation and physiological responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas 78712, United States
References (47)
Show source-provided references
1. Ferrari M. · Nat. Rev. Cancer · 2005 · 5 · 16110.1038/nrc1566 ↗
2. Lindner J. R. · Nat. Rev. Drug Discovery · 2004 · 3 · 52710.1038/nrd1417 ↗
3. Goldberg B. B. · Ultrasound Med. Biol. · 1994 · 20 · 31910.1016/0301-5629(94)90001-9 ↗
4. Frinking P. J. · Ultrasound Med. Biol. · 2000 · 26 · 96510.1016/S0301-5629(00)00229-5 ↗
5. Anderson C. R. · Invest. Radiol. · 2011 · 46 · 21510.1097/RLI.0b013e3182034fed ↗
6. Tran B. C. · IEEE Trans Ultrason. Ferroelectr. Freq. Control · 2003 · 50 · 129610.1109/TUFFC.2003.1244746 ↗
7. Lin C.-Y. · Ultrasound Med. Biol. · 2010 · 36 · 146010.1016/j.ultrasmedbio.2010.06.003 ↗
8. Wamel A. Van · J. Controlled Release · 2006 · 112 · 14910.1016/j.jconrel.2006.02.007 ↗
9. Hannah A. · Proc. SPIE · 2011 · 7899 · 78992010.1117/12.875368 ↗
10. Yuan F. · Cancer Res. · 1995 · 55 · 3752
11. Dayton P. A. · Drug Dev. Res. · 2006 · 67 · 4210.1002/ddr.20065 ↗
12. Martin A. L. · Ultrasound Med. Biol. · 2012 · 38 · 179910.1016/j.ultrasmedbio.2012.05.013 ↗
13. Rapoport N. · Ultrasound Med. Biol. · 2010 · 36 · 41910.1016/j.ultrasmedbio.2009.11.009 ↗
14. Rapoport N. · J. Controlled Release · 2011 · 153 · 410.1016/j.jconrel.2011.01.022 ↗
15. Sheeran P. S. · Biomaterials · 2012 · 33 · 326210.1016/j.biomaterials.2012.01.021 ↗
16. Riess J. G. · Biomaterials · 1998 · 19 · 152910.1016/S0142-9612(98)00071-4 ↗
17. Rapoport N. Y. · J. Controlled Release · 2009 · 138 · 26810.1016/j.jconrel.2009.05.026 ↗
18. Rapoport N. · J. Natl. Cancer Inst. · 2007 · 99 · 109510.1093/jnci/djm043 ↗
19. Nam K.-H. · AIP Conf. Proc. · 2009 · 1113 · 12410.1063/1.3131396 ↗
20. Wang C.-H. · Biomaterials · 2012 · 33 · 193910.1016/j.biomaterials.2011.11.036 ↗
21. Kripfgans O. D. · Ultrasound Med. Biol. · 2000 · 26 · 117710.1016/S0301-5629(00)00262-3 ↗
22. Giesecke T. · Ultrasound Med. Biol. · 2003 · 29 · 135910.1016/S0301-5629(03)00980-3 ↗
23. Sheeran P. S. · Curr. Pharm. Des. · 2012 · 18 · 215210.2174/138161212800099883 ↗
24. Reznik N. · Phys. Med. Biol. · 2012 · 57 · 720510.1088/0031-9155/57/21/7205 ↗
25. Strohm E. · Biomed. Opt. Express · 2011 · 2 · 143210.1364/BOE.2.001432 ↗
26. Wilson K. · Nat. Commun. · 2012 · 3 · 61810.1038/ncomms1627 ↗
27. Bell A. G. · Am. J. Sci. · 1880 · 30510.2475/ajs.s3-20.118.305 ↗
28. Funovics M. · Anal. Bioanal. Chem. · 2003 · 377 · 95610.1007/s00216-003-2199-0 ↗
29. Sakka S. G. · Curr. Opin. Crit. Care · 2007 · 13 · 20710.1097/MCC.0b013e328012b268 ↗
30. Weissleder R. A · Nat. Biotechnol. · 2001 · 19 · 31610.1038/86684 ↗
31. Jo F. F. · J. Biomed. Opt. · 1999 · 4 · 39210.1117/1.429952 ↗
32. Cherrick G. R. · J. Clin. Invest. · 1960 · 39 · 59210.1172/JCI104072 ↗
33. Hobbs S. K. · Proc. Natl. Acad. Sci. U.S.A. · 1998 · 95 · 460710.1073/pnas.95.8.4607 ↗
34. Torchilin V. · Adv. Drug Delivery Rev. · 2011 · 63 · 13110.1016/j.addr.2010.03.011 ↗
35. Iyer A. K. · Drug Discovery Today · 2006 · 11 · 81210.1016/j.drudis.2006.07.005 ↗
36. Wilson K. · Proc. SPIE · 2010 · 7576 · 75760M10.1117/12.841431 ↗
37. Landsman M. L. · J. Appl. Physiol. · 1976 · 40 · 57510.1152/jappl.1976.40.4.575 ↗
38. Fujita T. · J. Drug Targeting · 1994 · 2 · 15710.3109/10611869409015905 ↗
39. Lowe K. C. · J. Fluorine Chem. · 2001 · 109 · 5910.1016/S0022-1139(01)00374-8 ↗
40. Reznik N. · Ultrasound Med. Biol. · 2011 · 37 · 127110.1016/j.ultrasmedbio.2011.05.001 ↗
41. Kaneda M. M. · Ann. Biomed. Eng. · 2009 · 37 · 192210.1007/s10439-009-9643-z ↗
42. Murawa D. · Br. J. Surg. · 2009 · 96 · 128910.1002/bjs.6721 ↗
43. Intes X. · Med. Phys. · 2003 · 30 · 103910.1118/1.1573791 ↗
44. Rajian J. R. · Opt. Express · 2011 · 19 · 1433510.1364/OE.19.014335 ↗
45. Barber E. J. · J. Phys. Chem. · 1956 · 60 · 50410.1021/j150538a030 ↗
46. Rapoport N. Y. · Bubble Sci., Eng., Technol. · 2009 · 1 · 3110.1179/175889709X446516 ↗
47. Rodriguez V. B. · J. Biomed. Opt. · 2008 · 13 · 01402510.1117/1.2834296 ↗